Loading...

Advanced ADCs And Expanding Emerging Markets Will Redefine Oncology Treatment

Published
13 Jul 25
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
-24.1%
7D
4.1%

Author's Valuation

JP¥6.8k48.5% undervalued intrinsic discount

AnalystHighTarget Fair Value